Dolores Jean SCHENDEL,Susanne WILDE,Bernhard FRANKENBERGER,Wolfgang UCKERT
申请号：
US15822970
公开号：
US20180162921A1
申请日:
2017.11.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention is directed to a high affinity T cell receptor (TCR) against a tumor-associated antigen, an isolated nucleic acid molecule encoding same, a T cell expressing said TCR, and a pharmaceutical composition for use in the treatment of diseases involving malignant cells expressing said tumor-associated antigen.
